Antimutagenicity of benzo[a]phenothiazines in chemically induced mutagenesis

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3625-3628

  Tanaka, Masaru ^a   Wayda, Kornélia ^a   Molnár, Joseph ^a   Motohashi, Noboru ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antimutagenicity; Phenothiazines

Indexed keywords

ANTIMUTAGENIC AGENT; BENZO[A]PHENOTHIAZINE; CHLORPROMAZINE; MUTAGENIC AGENT; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; UNCLASSIFIED DRUG; 1,2-DIAMINO-4-NITROBENZENE; 4 NITRO 1,2 PHENYLENEDIAMINE; CARCINOGEN; PHENYLENEDIAMINE DERIVATIVE;

ARTICLE; CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DRUG POTENCY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; STRUCTURE ACTIVITY RELATION; DRUG EFFECT; MUTAGEN TESTING;

ANTIMUTAGENIC AGENTS; ANTIPSYCHOTIC AGENTS; CARCINOGENS; MUTAGENICITY TESTS; PHENOTHIAZINES; PHENYLENEDIAMINES; SALMONELLA TYPHIMURIUM;

EID: 0030300055     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Gordon M. (Eds.): Medicinal Chemistry, Vol. 4: Psychopharmacological Agents. Vol. 3. Academic Press, New York, 1974.
2. Katz J, Kunofsky S, Patton RE, Allaway NC: Cancer mortality among patients in New York mental hospitals. Cancer 64: 2194-2199, 1967.
3. Bishop JM: The molecular genetics of cancer. Science 235, 305, 1987
4. Weinberg RA: Tumor suppressor genes. Science 254: 1138, 1991.
5. Land H, Parada KF, Weinberg RA: Cellular oncogenes and multistep carcinogenesis. Science, 222, 771,1983.
6. Tanaka T: Cancer Chemoprevention. Cancer J. 5 (1) 11-16, 1992.
7. Weinberg RA: Oncogens, antioncogens on the molecular bases of mutistep carcinogenesis. Cancer Res 49: 3713-3721, 1989.
8. Fiala ES, Reddy B, Weisburger JH: Naturally occuring anticarcinogenic substances in food stuffs. Ann Rev Nurt 5: 295-321, 1985.
9. Boone CW, Kelloff GJ, Malone WE: Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res 50: 2-9, 1990.
10. Heller CS, Sevag MG: Prevention of the emergence of drug resistance in bacteria by acridines, phenothiazines and dibenzocycloheptenes. Appl Microbiol 14: 879-884, 1966.
11. Calle LM, Sullivan PD, Nettleman MD, Ocasio IJ, Blazyk J, Jollick J: Antioxidants and the mutagenicity of benzo[a]pyrene and some derivatives. Biochem Biophys Res Commun 85: 351-356, 1978.
12. Kittle Jr JD, Calle LM, Sullivan PD: The effect of substituted phenothiazines on the mutagenicity of benzo[a]pyrene. Mutation Res 80: 259-264, 1981.
13. Bichel MH: N-Oxide formation and related reactions in drug metabolism. Xenobiotica 1: 313-319, 1971.
14. Sullivan PD, Calle LM, Ocasio IJ, Kettle Jr. JD, Ellis LE: The effect of antioxidants on the mutagenicity of benzo[a]pyrene and derivatives. In: Bjorseth A, Dennis AJ (Eds.) Polynuclear Aromatic Hydrocarbons: Chemistry and Biological Effects. Battelle, Columbus, pp. 163-175, 1980.
15. Omishi SI, McConnell HM: Interaction of the radical ion of chlorpromazine with deoxyribonucleic acid. J Am Chem Soc 87: 2293, 1965.
16. Motohashi H: Test for antitumor activities of phenothiazines and phenoxazines. Yakugaku Zasshi 103: 364-371, 1983.
17. Maron DM, Ames BN: Revised methods for the Salmonella mutagenicity test. Mutation Res 113: 173-215, 1983.
18. Molnar J, Foldeak S, Nakamura MJ, Rausch H, Domokos K, Szabo M: Antiplasmid activity: loss of bacterial resistance to antibiotics. APMIS Supp1 30: 24-31, 1992.
19. Molnar J, Mandi Y, Regely K, Tarnoky K, Nakamura MJ: Inhibition of biological effects of endotoxins by phenothiazines. In Vivo 6: 205-209, 1992.
20. Motohashi N, Sakagami H, Kurihara T, Ferenczy L, Csuri K, Molnar J: Antimicrobial activity of phenothiazines, benzo[a]phenothiazines and benz[a]acridines. Anticancer Res 12: 1207-1210, 1992.
21. Motohashi N, Sakagami H, Kurihara T, Csuri K, Molnar J: Antiplasmid activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines. Anticancer Res 12: 135-139, 1992.
22. Molnar J, Galfi M, Lozsa A, Nakamura MJ: Inhibition of bacterial plasmid replication by stereoselective binding by tricyclic psychopharmacons. Res Commun Chem Pathol Pharmacol 43: 235-249, 1984.
23. Molnar J, Beladi I, Foldes I: Studies on antituberculotic action of some phenothiazine derivatives in vitro. Zentralbl Bakteriol Orig A 239: 521-526, 1977.
24. Molnar J, Mandi Y, Holland IB, Schneider G: Antibacterial effect, plasmid curing activity and chemical structure of some tricyclic compounds. Acta Microbiol Acad Sci Hung 24: 1-6, 1977.
25. Molnar J, Mandi Y, Kiraly J: Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine. Acta Microbiol Acad Sci Hung 23: 45-54, 1976.
26. Motohashi N, Gollapudi SR, Emrani J, Bhattiprolu KR: Antitumor properties of phenothiazines. Cancer Invest 9: 305-319, 1991.
27. Jacobi A: Methylthionin hydrochloride in inoperable cancer. J Am Med Assoc 47: 1545-1546, 1906.
28. Hasida M: Uber die Antikanzerogenitat von Kunstlichen Anilinfarbstoffen bei der experimentellen Hepatomerzeugung I. Gann 35: 164-166, 1941.
29. Schellenberg J: Action of chlorpromazine und imipramine on cultures of some malignant and normal tissues. Med Exptl 5: 467-472, 1961.
30. Polliack A, Levi IS: Antineoplastic effect of chlorpromazine in chemical carcinogenesis in the hamster cheek pouch. Cancer Res 32: 1912-1915, 1972.
31. Popenenkova ZA, Romanovskaya MG: Effects of chlorpromazine, chloracizine, and vetrazine on catecholamines and their metabolism in rats infected with pneumococcus: Pathol Fiziol Eksp Ter 15: 77-79, 1971.
32. Hoskin FCCG: Effect of inhibitors on the metabolism of specifically labeled glucose by brain. Biochim Biophys Acta 40: 309-313, 1960.
33. Wollemann M, Keleti T: Mechanism of the dehydrogenase inhibition of phenothiazines. Arzneimittelforsch 12: 360-363, 1962.
34. Caneiro J, Cardoso ACSO: Influence of chlorpromazine on nuclear and cytoplasmic uptake of S35-methionine. Experientia 18: 220-222, 1962.
35. Berger M, Strecker HJ, Waelsch H: Action of chlorpromazine on oxidative phosphorylation of live and brain mitochondria. Nature 177: 1234-1235, 1956.
36. Masurat T, Greenberg SM, Rice EG et al: The action of chlorpromazine on yeast hexokinase. Biochem Pharmocol 5: 20-26, 1960.
37. George KC, Singh BB: Potentiation of radiation response of a mouse fibrosarcoma by phenothiazine drugs. Ind J Exp Biol 22: 305-307, 1984.
38. Badger GM, Elson LA, Haddow A, Hewett CL, Robinson AM: The inhibition of growth by chemical compounds. Proc R Soc London B 130: 255-299, 1942.
39. Buu-Hoi NP, Lecocq J: Substituted benzophenothiazines. Compt Rend Acad Sci 218: 648-650, 1944.
40. Gerald JT, Shirley DA: Nitrogen mustard derivatives in the phenothiazine and henzophenothiazine series. J Mod Chem 11: 622-623, 1968.